Acquisition of ID business from Omega Diagnostics Accelerating profitability by expanding the Lab21 business with complimentary products
Visit PageCategory: Uncategorized
Update on unsecured debt facility
Update on unsecured debt facility Paris, France and Camberley, UK – 19 June 2018 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces the conversion of the €4.0m unsecured, anti-dilutive debt facility (the “Advance”) from a French institutional investor, into an unsecured Convertible Bond (the “Convertible Bond”) further to the
Visit PageRESULTS OF ANNUAL GENERAL MEETING
AGM results statement June 2018 Paris, France and Cambridge, UK – 12 June 2018 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, yesterday held its Annual General Meeting (AGM). The results of the AGM are set out in the table below, with the Company pleased to announce that all resolutions
Visit PageNOVACYT LAUNCHES NEW PRODUCT IN INFECTIOUS MONONUCLEOSIS
New product launch under PathFlow brand First in a series of new product launches in infectious diseases
Visit PageNovacyt expands distribution presence in Asia Pacific
Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, today announces that it has appointed MDL Asia Pty Ltd (“MDL” or “MDL Asia”) as its marketing and distribution partner in the Asia Pacific region, excluding Greater China. Download press release
Visit PageNovacyt Named in Deloitte Technology Fast 500
Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, has been named in the Deloitte Technology Fast 500 for Europe, Middle East and Africa. Download press release
Visit PageNovacyt Named in Deloitte Technology Fast 50
Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, has been named in the Deloitte Technology Fast 50 in France. Download press release
Visit PageNovacyt appoints Anthony Dyer as Finance Director
Novacyt (Mmemo: ALNOV – FR0010397232) announces that Anthony Dyer will become Finance Director. Download press release
Visit PageNovacyt strengthens board
Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics is pleased to announce the addition of new members to its Board as the Company prepares for the next stages of growth. Download press release
Visit PageNovacyt appoints new Group Commercial Director
Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, has appointed Manuela Gazzard as Commercial Director. Download press release
Visit Page